Skip Navigation



JAC Advance Access published online on February 8, 2007
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl532
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
59/4/799    most recent
dkl532v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Walsh, T. R.
Right arrow Articles by Jones, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, T. R.
Right arrow Articles by Jones, R. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

Comment on: Occurrence, prevalence and genetic environment of CTX-M ß-lactamases in Enterobacteriaceae from Indian hospitals

T. R. Walsh1,*, M. A. Toleman1 and R. N. Jones2

1 Department of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK 2 JMI Laboratories, North Liberty, IA 52317, USA

* Corresponding author. E-mail: WalshTR@Cardiff.ac.uk

Key Words: India , ESBLs , Escherichia coli , Klebsiella spp

The first 10% of the full text of this article appears below.

Sir,

We read with interest the recent publication by Ensor et al.1 and concur with their concerns regarding the high frequency of extended-spectrum ß-lactamase (ESBL) genotypes in India. However, in 2002 The Indian Antimicrobial Resistance Study Group published their findings on broad-spectrum ß-lactam resistance and ESBL phenotypes in Enterobacteriaceae including Salmonella spp. The isolates were part of the MYSTIC Programme and were . . . [Full Text of this Article]

Transparency declarations


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
M. Shahid, M. Singhai, A. Malik, I. Shukla, H. M. Khan, F. Shujatullah, and F. Tahira
In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum {beta}-lactamase
J. Antimicrob. Chemother., July 1, 2007; 60(1): 187 - 188.
[Full Text] [PDF]